Bio​

Distinguished professor and researcher at Stanford University and co-founder of Turn Biotechnologies, a cutting-edge company focused on cellular regeneration and longevity research. Sebastiano is revolutionizing the understanding of aging through the ERA (Epigenetic Reprogramming of Aging) technology, which promises to reverse signs of aging without compromising cellular identity. This innovative technique offers new possibilities for tissue regeneration and anti-aging treatments, paving the way for therapies that could slow down the aging process and improve quality of life. Sebastiano continues to lead and collaborate with various scientific institutions to redefine the future of regenerative medicine.